Cargando…

Quantitative PCR Evaluation of Cellular Immune Responses in Kenyan Children Vaccinated with a Candidate Malaria Vaccine

BACKGROUND: The T-cell mediated immune response plays a central role in the control of malaria after natural infection or vaccination. There is increasing evidence that T-cell responses are heterogeneous and that both the quality of the immune response and the balance between pro-inflammatory and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mwacharo, Jedidah, Dunachie, Susanna J., Kai, Oscar, Hill, Adrian V. S., Bejon, Philip, Fletcher, Helen A.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792766/ https://www.ncbi.nlm.nih.gov/pubmed/20037644 http://dx.doi.org/10.1371/journal.pone.0008434

Ejemplares similares

Correction: Quantitative PCR Evaluation of Cellular Immune Responses in Kenyan Children Vaccinated with a Candidate Malaria Vaccine
por: Mwacharo, Jedidah, et al.
Publicado: (2011)

Clearance of Asymptomatic P. falciparum Infections Interacts with the Number of Clones to Predict the Risk of Subsequent Malaria in Kenyan Children
por: Liljander, Anne, et al.
Publicado: (2011)

Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model
por: Dunachie, Susanna, et al.
Publicado: (2015)

Profiling the host response to malaria vaccination and malaria challenge
por: Dunachie, Susanna, et al.
Publicado: (2015)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 (E) on blood stage immunity in young Kenyan children
por: Ndungu, Francis M., et al.
Publicado: (2019)

A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya
por: Bejon, Philip, et al.
Publicado: (2006)

A Statistical Interaction between Circumsporozoite Protein-Specific T Cell and Antibody Responses and Risk of Clinical Malaria Episodes following Vaccination with RTS,S/AS01E
por: Ndungu, Francis M., et al.
Publicado: (2012)

Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
por: Mugo, Robert M., et al.
Publicado: (2021)

MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines
por: Berthoud, Tamara K., et al.
Publicado: (2009)

MIG and the Regulatory Cytokines IL-10 and TGF-β1 Correlate with Malaria Vaccine Immunogenicity and Efficacy
por: Dunachie, Susanna J., et al.
Publicado: (2010)

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01(E) and Protection against P falciparum Clinical Malaria
por: Olotu, Ally, et al.
Publicado: (2011)

Corrigendum to “MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines” [J. Immunol. Methods 340 (2009) 33–41]
por: Berthoud, Tamara K., et al.
Publicado: (2011)

FEEDBACK OF RESEARCH FINDINGS FOR VACCINE TRIALS: EXPERIENCES FROM TWO MALARIA VACCINE TRIALS INVOLVING HEALTHY CHILDREN ON THE KENYAN COAST
por: Gikonyo, Caroline, et al.
Publicado: (2013)

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01(E) on Blood Stage Immunity in Young Children
por: Bejon, Philip, et al.
Publicado: (2011)

Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

The Ratio of Monocytes to Lymphocytes in Peripheral Blood Correlates with Increased Susceptibility to Clinical Malaria in Kenyan Children
por: Warimwe, George M., et al.
Publicado: (2013)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children
por: Lusingu, John, et al.
Publicado: (2010)

Controlled human malaria infection in Kenyan adults: A safe model that could accelerate assessment of novel drugs and vaccines in malaria endemic populations
por: Hodgson, Susanne, et al.
Publicado: (2014)

Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast
por: Kangoye, David Tiga, et al.
Publicado: (2016)

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data
por: Warimwe, George M, et al.
Publicado: (2013)

Long-lasting insecticide-treated net use and malaria infections on the Kenyan coast
por: Kamau, Alice, et al.
Publicado: (2022)

Taking social relationships seriously: Lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast
por: Gikonyo, Caroline, et al.
Publicado: (2008)

Spatial–temporal clustering of malaria using routinely collected health facility data on the Kenyan Coast
por: Kamau, Alice, et al.
Publicado: (2021)

Correlation of Memory T Cell Responses against TRAP with Protection from Clinical Malaria, and CD4(+) CD25(high) T Cells with Susceptibility in Kenyans
por: Todryk, Stephen M., et al.
Publicado: (2008)

Readiness of the Kenyan public health sector to provide pre‐referral care for severe paediatric malaria
por: Amboko, Beatrice, et al.
Publicado: (2022)

Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
por: Ogwang, Caroline, et al.
Publicado: (2013)

Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast
por: Kariuki, Symon M., et al.
Publicado: (2011)

Correction: Correlation of Memory T Cell Responses against TRAP with Protection from Clinical Malaria, and CD4(+) CD25(high) T Cells with Susceptibility in Kenyans
por: Todryk, Stephen M., et al.
Publicado: (2011)

Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children
por: Withers, Mark R, et al.
Publicado: (2006)

Changing Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector Control
por: Snow, Robert W., et al.
Publicado: (2015)

Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast
por: Kamau, Alice, et al.
Publicado: (2022)

Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study
por: Jao, Irene, et al.
Publicado: (2020)

Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya
por: Bejon, Philip, et al.
Publicado: (2007)

Response to “Poor control vaccines in two randomised trials of malaria vaccine?”
por: Bejon, Philip, et al.
Publicado: (2009)

Vaccines against malaria
por: Hill, Adrian V. S.
Publicado: (2011)

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies
por: Mugo, Robert M., et al.
Publicado: (2023)

Vaccine candidate discovery for the next generation of malaria vaccines
por: Tuju, James, et al.
Publicado: (2017)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1
por: Fletcher, Helen A., et al.
Publicado: (2008)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
por: Pathan, Ansar A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_erl7eg1er2b9et6ulfuf43331t